ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1046

Modulatory Effect of Adiponectin on Apoptosis and Proliferation of Synovial Fibroblasts from Rheumatoid Arthritis Patients

Wei Yu1, Wenfeng Tan2 and Miaojia Zhang3, 1Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, nanjing, China, 2Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, CHINA., Nanjing, China, 3the first affliated hospital with nanjing medical univercity, nanjing, China

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose We previously reported that adiponectin (AD) is highly expressed in the inflammatory joint of rheumatoid arthritis (RA) patients and closely correlated with progressive bone erosion, but the mechanism remained largely unclear. Synovial fibroblasts from RA patients (RASFs) have been suggested a unique characteristic of resistance to apoptosis that contributes to synovial hyerplasia, synovitis and bone erosion in RA. In this study, we tested the role of AD on apoptosis and proliferation in primary RASFs.

Methods RASFs was treated with PBS in the absence and presence of AD (0.1, 1 or 10 μg/ml) for 24 h to 72 h and the frequencies of apoptosis cells were measured by flow cytometry. CCK-8 and direct microscopic count were used to analyze the proliferation of RASFs after stimulated with AD. Real-time PCR was used to test the expression of Bcl-2, Bax, p53, CDK4, PCNA, IL-6, IL-8 and MMP-3 mRNA in RASFs. Western blot was used to test the protein expression of Bcl-2 and Bax and activation of signal transduction pathways.

Results The frequencies of apoptosis cells were significant decreased in RASFs after AD stimulation. AD could promote proliferation of RASFs compared with untreated it. A markedly increased CDK4 and PCNA mRNA expression and a decreased level of p53 mRNA were observed in RASFs after treated with AD. The levels of IL-6, IL-8 and MMP-3 expression also obviously increased in RASFs upon AD stimulation. Western blot indicated that AD could rapidly triggered p-Akt and p-ERK activity and then induced Bcl-2, but decreased Bax expression in RASFs.

Conclusion Our findings indicate that AD could affect apoptosis and proliferation of RASFs via Akt and ERK pathway, suggesting a critical role of AD on disease progression in RA.


Disclosure:

W. Yu,
None;

W. Tan,
None;

M. Zhang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modulatory-effect-of-adiponectin-on-apoptosis-and-proliferation-of-synovial-fibroblasts-from-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology